Physician profile
Shogofa Halimi
NPI 1942079504
$1,118.53
in general payments reported to CMS, 2019-2025
16 companies · $614 in 2025
The $614 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $505 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $324.39 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Dexcom, INC. | $155.55 | 2024-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $145.49 | 2024 | Farxiga, Airsupra |
| Sanofi-Aventis U.S. LLC | $140.93 | 2024 | |
| Glaxosmithkline, LLC. | $66.09 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $49.37 | 2025 | |
| Lilly USA, LLC | $36.22 | 2024-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $33.78 | 2025 | General - Pain Management |
| Exact Sciences Corporation | $30.39 | 2024-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $26.20 | 2025 | |
| Dynavax Technologies Corporation | $24.76 | 2025 | Heplisav-B |
| Astellas Pharma US INC | $23.04 | 2025 | Veozah |
| Axsome Therapeutics, INC. | $16.85 | 2025 | Auvelity |
| Sumitomo Pharma America, INC. | $16.70 | 2025 | Gemtesa |
| Abbvie INC. | $15.67 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $13.10 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shogofa Halimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.